Your browser doesn't support javascript.
loading
A Derivative of Piperlongumine and Ligustrazine as a Potential Thioredoxin Reductase Inhibitor in Drug-Resistant Hepatocellular Carcinoma.
Qian, Jianqiang; Xu, Zhongyuan; Zhu, Peng; Meng, Chi; Liu, Yun; Shan, Wenpei; He, Ang; Gu, Yipeng; Ran, Fansheng; Zhang, Yanan; Ling, Yong.
Afiliación
  • Qian J; Medical College, Nantong University, Nantong 226001, People's Republic of China.
  • Xu Z; School of Pharmacy and Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Targets, Nantong University, Nantong 226001, People's Republic of China.
  • Zhu P; School of Pharmacy and Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Targets, Nantong University, Nantong 226001, People's Republic of China.
  • Meng C; Medical College, Nantong University, Nantong 226001, People's Republic of China.
  • Liu Y; School of Pharmacy and Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Targets, Nantong University, Nantong 226001, People's Republic of China.
  • Shan W; School of Pharmacy and Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Targets, Nantong University, Nantong 226001, People's Republic of China.
  • He A; School of Pharmacy and Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Targets, Nantong University, Nantong 226001, People's Republic of China.
  • Gu Y; School of Pharmacy and Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Targets, Nantong University, Nantong 226001, People's Republic of China.
  • Ran F; School of Pharmacy and Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Targets, Nantong University, Nantong 226001, People's Republic of China.
  • Zhang Y; School of Pharmacy and Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Targets, Nantong University, Nantong 226001, People's Republic of China.
  • Ling Y; Medical College, Nantong University, Nantong 226001, People's Republic of China.
J Nat Prod ; 84(12): 3161-3168, 2021 12 24.
Article en En | MEDLINE | ID: mdl-34806369

Texto completo: 1 Colección: 01-internacional Asunto principal: Pirazinas / Reductasa de Tiorredoxina-Disulfuro / Carcinoma Hepatocelular / Resistencia a Antineoplásicos / Dioxolanos / Inhibidores Enzimáticos / Neoplasias Hepáticas Límite: Humans Idioma: En Revista: J Nat Prod Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Asunto principal: Pirazinas / Reductasa de Tiorredoxina-Disulfuro / Carcinoma Hepatocelular / Resistencia a Antineoplásicos / Dioxolanos / Inhibidores Enzimáticos / Neoplasias Hepáticas Límite: Humans Idioma: En Revista: J Nat Prod Año: 2021 Tipo del documento: Article